Why Should Regulators Consider Using Patient Preferences in Benefit-risk Assessment?

    Research output: Contribution to journalArticleAcademicpeer-review

    26 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1-4
    JournalPharmacoEconomics
    Volume32
    Issue number1
    DOIs
    Publication statusPublished - 2014

    Keywords

    • METIS-302381
    • IR-89396

    Cite this